In addition to the lipid lowering activity, statins act positively as a neuro-protective agent in some clinical cases such as Alzheimer's disease, brain injury, ischemia and seizures. Alzheimer's disease is a progressive neurodegenerative disorder representing the most common cause of dementia in the elderly population. Central STZ administration developed numerous behavioral, neurochemical and structural features that resembled those found in human Alzheimer's disease. The results of the present study showed a significant increase in the expression of glial fibrillary acidic protein in the groups of rats administered intrathecal injection of streptozocin when put side by side with the control one. A reduction in this marker observed in the group administered 20 mg/kg atorvastatin combined with a single intrathecal injection of streptozocin when compared to group taken streptozocin alone. Anti-oxidant state represented by glutathione reductase showed a significant increase in the expression of this marker in the groups that administered 5, 10 and 20 mg/kg atorvastatin after intrathecal injection of streptozocin in compared with the group administered streptozocin alone. However, a significant reduction in this marker observed in the group administered streptozocin alone when compared with control group. A significant increase in the neuronal nitric oxide synthase enzyme in the hippocampus of rats administered intrathecal injection of streptozocin. Also, a reduction in this marker observed in the groups treated with 10 and 20 mg/kg atorvastatin combined with a single intrathecal injection of streptozocin when put side by side with group taken streptozocin alone. We can conclude from the results that administration of streptozocin intrathecally lead to a model of Alzheimer's disease indicated by brain damage that may be improved by atorvastatin treatment but in a dose dependent manner.
tube, and continued for 30 days. Group 5 animals were administered intrathecal injection of 3 mg/kg Streptozocin as a single dose. At the same day, 20 mg/kg/day Atorvastatin were administered in the form of oral suspension, by using oral gavage tube, continued for 30 days. All animals kept under controlled conditions of temperature of (22 ± 10 °C) with light schedule of 12-12 hours light/dark cycles and the animal house was provided with an air vacuum. Tap water and foods in the form of pellets were accessible freely to the animals.
The animals were kept for 2 weeks in the mentioned conditions before starting treatment to be adapted to the environment of the animal house. All animals in this study were dissected under anesthesia using diethyl ether at day 31. With the animals under anesthesia and the heart still beating, heads were decapitated for extraction of the brain.
Samples Preparation for histological studies
Immediately after separation, the specimens were fixed individually in 10% formalin buffer solution for 24 hours at room temperature, followed by a dehydration step, by immersing it in a gradually increasing concentration of alcohol. Then, the tissues were kept in xylene for one hour under a temperature of 60C, and then embedding it in paraffin wax.
Staining for general morphology
5μm-thick sections were cut by a rotary microtome, sequentially mounted onto microscope slides, and stained with Hematoxylin and Eosin.
Immunohistochemistry for detection of neuronal Nitric Oxide Synthase, Glial Fibrillary Acidic Protein and Glutathione reductase expression in paraffin-embedded sections:
Paraffin embedded blocks were sectioned at 5μm. The sections were processed for nNOS, GFAP and GR staining using a commercially available kit (provided by Abcam, UK). In brief, the sections were positioned on a positively charged slide. then the sections were deparaffinized and rehydrated through a descending alcohol concentrations followed by distilled water. The sections were incubated with sodium citrate buffer in the humidity-heat chamber for antigen retrieval. Then, the endogenous peroxidase activity was inactivated with hydrogen peroxide. The non-specific bindings were blocked with a protein-blocking reagent. The sections were incubated with rabbit polyclonal anti nNOS antibody, Anti rabbit polyclonal anti GFAP antibody and anti rabbit polyclonal anti GR antibody. In sequence, the sections were incubated with horseradish peroxidase conjugate and then with complement solution. Finally, the reactions were revealed with 3-3'diaminobenzidine (provided by Abcam, UK) and the sections were counterstained with hematoxylin.
Slides were examined with high magnification power to semiquantitatively identify focally and completely stained cells that are defined as positive for the markers.
Neuronal Nitric Oxide Sunthase (Nnos)
The immunostaining was graded in five classes according to the percentage of stained tissue: 0= when the staining was absent, 1=when the percentage of stained tissue varied from 1% -25%, 2=when the percentage of stained tissue varied from 26%-50%, 3=when the percentage of stained tissue varied from 51%-75% and 4=when the percentage of stained tissue was superior to 75%.
Glutathione reductase (GR)
An immunohistochemical based scoring system was utilized for analyses of GR as percentage of positive stained cells per field in a blind fashion, and the scores calculated as following :0 = no stain %, 1 = <15%, 2 = 15-25%, 3 = 25-50%, 4 = 50-75% and 5 = >75-100%
Glial Fibrillary Acidic Protein (GFAP)
Scoring of GFAP expression was done for percentage of staining intensity per field as following: 0 = none, 1 =< 5%, 2 =5-25% , 3 = 25-75% and 4 =75-100%.
Statistical analysis
Statistical analysis was performed using Graphpad Prism 5. Data were tested for normality according to Shapiro test. Analysis of variance (ANOVA) was used, and Kruskal-Wallise were performed.
Comparisons among groups were submitted according to Dunn's Multiple Comparison Test. P < 0.05 was considered statistically significant.
Results

Effects of streptozocin alone and various doses of atorvastatin combined with streptozocin on glial fibrillary acidic protein (GFAP)
Our results make evident that there is a significant increase (p<0.05) in the score of the GFAP expression of the group of rats administered 3mg/kg of streptozocin intrathecally (Fig. 1A) when confronted with the control. On the contrary, there was no significant difference (P>0.05) when the control was compared with the groups treated with 3 mg/kg of streptozocin intrathecally combined with 5 mg/kg, 10 mg/kg and 20 mg/kg of atorvastatin orally. Non significant differences were noticed when streptozocin group wasopposed to both, the 5 mg/kg (Fig. 1B) and the 10 mg/kg (Fig. 1C) of the atorvastatin-streptozocin treated groups. Meanwhile, a significant decrease was observed (P<0.05) in the 20 mg/kg atorvastatin in addition to streptozocin group ( fig. 1D ) when set side by side against the streptozocin group. All the 5 mg/kg, 10 mg/kg and 20 mg/kg atorvastatin-streptozocin treated groups showed a non significant change (p>0.05) when compared with each other. The figure (2) authenticates the results given above on glial fibrillary acidic protein.
Effects of multiple doses of atorvastatin combined with streptozocin and streptozocin alone on glutathione reductase (GR)
Analysis of data makes certain that there is a significant decrease 
Effects of streptozocin alone and different doses of atorvastatin combined with streptozocin on neuronal Nitric Oxide Synthase (nNOS)
The result assures that there is a significant increase (P<0.05) in the score of the nNOS expression of the group administered 3 mg/kg of streptozocin intrathecally ( 
Discussion
After cellular injury, the GFAP is synthesized plentifully, thus, it represents itself more conspicuously within the reactive gliosis process 19 . Generalized astrogliosis, demonstrated by cellular hypertrophy and by an increase in expression of GFAP and astroglial S100B protein, was routinely observed in postmortem tissues from AD patients 20, 21, 22, 23 . Importantly, activated astrocytes are capable of accumulating large amounts of Aβ; the latter being taken up by astrocytes in association with neuronal debris. Beside, reactive astrocytes seem to accumulate large amounts of neuronal subtype of nicotinic cholinoreceptor (α-7nAChRs), which is known to have an exceptionally high affinity to β-amyloid. Processes of activated astrocytes were also reported to be a part in plaques formation 24 . The present results show that there is a significant increase in the expression of GFAP in the group of rats administered 3 mg/kg of streptozocin intrathecally and this come in agreement with previous study 
